Evidence map›Paper›PMID 40625204›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2025

Lung Cancer Screening among Adults Older than Medicare's Upper Age Eligibility Criteria.

Monica Hernandez, Kristin G Maki, Hui Zhao, Iakovos Toumazis, Robert J Volk

Abstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Monica HernandezHealth Services Research (HSR) Department, University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-4752-0938
Kristin G MakiKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0003-2980-7118
Hui ZhaoHealth Services Research (HSR) Department, University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-4742-1139
Iakovos ToumazisHealth Services Research (HSR) Department, University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-3462-2137
Robert J VolkHealth Services Research (HSR) Department, University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-8811-5854

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Cancer Prevention and Research Institute of Texas (CPRIT) RP230213Cancer Prevention and Research Institute of Texas (CPRIT) RP240508National Cancer Institute (NCI) P30CA16672National Institutes of Health (NIH) P30CA022453NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA022453University of Texas MD Anderson Cancer Center (MD Anderson)
6 · The paper itself

Abstract

Implications on the loss of lung cancer screening (LCS) coverage among Medicare recipients aged 77+ years have not been explored. We use a 2022 Behavioral Risk Factor Surveillance System dataset to examine LCS patterns of screen-eligible adults across three age groups: 65 to 70, 71 to 77, and 78 to 79 years. In descriptive analyses, LCS-eligible respondents are compared by screening status across each age category. In regression analyses, we explore various sociodemographic and health-related factors that may help explain age-related differences between these groups. Less than a third of our sample reported LCS in the last year (26.3%). Among eligible respondents, adults aged 78 to 79 years reported the highest LCS rates (32.0%), followed by adults aged 71 to 77 years (28.3%) and 65 to 70 years (24.2%). Respondents aged 78 to 79 years and 65 to 70 years with chronic obstructive pulmonary disease indicated significantly increased LCS odds [OR, 3.37; 95% confidence interval (CI), 1.12-10.11 and OR, 2.91; 95% CI, 1.98-4.27, respectively]. Respondents aged 78 to 79 years with history of a heart attack or kidney disease indicated significantly decreased LCS odds (OR, 0.08; 95% CI, 0.01-0.62 and OR, 0.06; 95% CI, 0.01-0.56, respectively). Respondents aged 71 to 77 years with coronary heart disease indicated a significantly decreased LCS odds (OR, 0.54; 95% CI, 0.30-0.96). Although loss of Centers for Medicare & Medicaid Services coverage for LCS is not associated with lower screening among Behavioral Risk Factor Surveillance System adults aged 78 to 79 years, clinicians should continue to consider the appropriateness of treatment for older LCS-eligible adults with chronic health conditions. PREVENTION RELEVANCE: Persons who reach the age of 78 years are no longer eligible for LCS coverage from Medicare. This study fills an important knowledge gap by comparing LCS patterns among a nationally representative sample of Medicare-eligible adults aged 78 to 79 years with their younger counterparts aged 65 to 77 years, for whom Centers for Medicare & Medicaid Services covers LCS. See related Spotlight, p. 655.

Indexed as

Early Detection of CancerEligibility DeterminationLung NeoplasmsMass ScreeningMedicareAgedAged, 80 and overAge FactorsBehavioral Risk Factor Surveillance SystemFemaleHumansMaleUnited States

Identifiers

PMID40625204
PMCPMC12478563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.